<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00346190</url>
  </required_header>
  <id_info>
    <org_study_id>CA-16</org_study_id>
    <nct_id>NCT00346190</nct_id>
  </id_info>
  <brief_title>The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.</brief_title>
  <official_title>A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Frosst Canada Ltd.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>McGill University Health Center</source>
  <brief_summary>
    <textblock>
      To determine whether administration of Alendronate early is more effective than late in the
      prevention of osteoporosis following a hip fracture
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2003</start_date>
  <completion_date type="Anticipated">April 2007</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <enrollment>10</enrollment>
  <condition>Osteoporosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alendronate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Male and Female aged &gt; 55 Low trauma hip fracture up to 90 days Be willing to submit to
        periodic bone mineral density radiographic studies of the spine &amp; 24 hr urine collection
        Written informed consent

        Exclusion Criteria:

          -  Disorders known to affect bone metabolism Not taking bisphosphonates within last 6
             months Drugs known to interfere with calcium metabolism within the lats 6 months prior
             to hip fracture serum calcium&gt; 2.65 mmol/L Treatment with any investigational drug
             within the last 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard Kremer, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Kremer, MD PhD</last_name>
    <phone>514-934-1934</phone>
    <phone_ext>32857</phone_ext>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Giselle Charrette, RN CONc</last_name>
    <phone>514-934-1934</phone>
    <phone_ext>35718</phone_ext>
    <email>giselle.charrette@muhc.mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mcgill University Health center</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Kremer, MD PhD</last_name>
      <phone>514-934-1934</phone>
      <phone_ext>32857</phone_ext>
    </contact>
    <investigator>
      <last_name>Richard Kremer, MD PhD FRCP(c)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 27, 2006</study_first_submitted>
  <study_first_submitted_qc>June 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2006</study_first_posted>
  <last_update_submitted>April 11, 2007</last_update_submitted>
  <last_update_submitted_qc>April 11, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2007</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Hip Fractures</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alendronate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

